Enact Stock Forecast
NASDAQ: ACTFinanceSpecialty InsurersUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ACT analyst consensus
Consensus (6 analysts)
none
Avg. price target
$50.20+9.56%
- Strong buy 0
- Buy 1
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Enact (2026-10-07), 1 rate the stock a buy or strong buy, 5 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $50.20, with a high estimate of $53.00 and a low estimate of $48.00. The average target implies upside of 9.6% from the current price of $45.82.
The spread between the highest and lowest targets is 10.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ACT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 1 | 17% |
| Hold | 5 | 83% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $48.00 | +4.76% |
| Average target | $50.20 | +9.56% |
| High target | $53.00 | +15.67% |